NSAIDs and PGE2 Levels in Vitrectomy Patients

NCT02361645 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Vitreous Inflammation

Interventions

DRUG: Ketorolac 0.5% eyedrops
DRUG: Indomethacin 0.5% eyedrops
DRUG: Bromfenac 0.09% eyedrops
DRUG: Nepafenac 0.1% eyedrops

Sponsor

Università degli Studi di Brescia